Example of muscle segmentation. by Charlotte Zaeske (12101949)

Subjects:

Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. Monocytes and NK cells purified from PBMC collected from 10 RZV recipients (demographics in S4 Table) before vaccination (D0) and 90 days post-vaccination (D90) were combined ex vivo and stimulated with VZV-rgE. A subset of D0 monocyte & NK cocultures was also treated with the TGFβ1 inhibitor LY (D0 LY), and a subset of D90 cocultures were supplemented with rhTGFβ1. The graph shows individual data points, means and p values calculated by Friedman test for repeated measures with FDR correction. LY treatment of cells collected on D0 significantly increased their activation to levels similar to D90. Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0. by Michael J. Johnson (5818168)

“…Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.…”

Graphs showing the temporal effects of temperature at the four different positions during a drilling sequence with guide drilling in two steps and final widening drilling (MIPS) an... by Marsel Ganeyev (21453399)

Subjects:

M^pro confers a significant reduction in growth in yeast caused by decreases in a variety of cellular proteins. by Jin Ou (16914305)

Summary map of all contacts with statistically significant SVM classifications. by Alexander P. Rockhill (6053618)

“…Yellow indicates an increase in time-frequency clusters during number trials versus inter-trial intervals while blue indicates a decrease in time-frequency clusters. …”

Significant variables in decreasing importance for varietal clustering based on Random forest method. by Wilfried Chevalier (10521466)

Spleen PAX5 significantly decreased in APRIL/BLyS blockade treated mice. by Natalie M. Bath (6316517)

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models. by Mark P. Labrecque (10011469)

Placebo test: Alternate DVs. by Vivek Astvansh (14310090)

Subjects:

Local RD analysis. by Vivek Astvansh (14310090)

Subjects:

External validity: Global RD analysis. by Vivek Astvansh (14310090)

Subjects:

Channels of REM. by Vivek Astvansh (14310090)

Subjects:

Local RD: RTW legislation. by Vivek Astvansh (14310090)

Subjects:

Robustness tests. by Vivek Astvansh (14310090)

Subjects:

Summary statistics. by Vivek Astvansh (14310090)

Subjects:

Density distribution of union vote shares. by Vivek Astvansh (14310090)

Subjects:

Placebo tests. by Vivek Astvansh (14310090)

Subjects:

RD Plot on REM. by Vivek Astvansh (14310090)

Subjects:

RD bandwidths. by Vivek Astvansh (14310090)

Subjects: